Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.
- DOI
- 10.1097/hjh.0000000000004422
- Published
- 2026 Aug 13
- Container
- Journal of hypertension
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/hjh.0000000000004422,
title = {Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.},
author = {Hüttl M and Miklovič M and Škaroupková P and Vaňourková Z and Kikerlová S and Sadowski J and Šnorek M and Sandner P and Červenka L},
year = {2026},
journal = {Journal of hypertension},
doi = {10.1097/hjh.0000000000004422},
url = {https://doi.org/10.1097/hjh.0000000000004422}
}RIS
TY - JOUR TI - Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME. AU - Hüttl M AU - Miklovič M AU - Škaroupková P AU - Vaňourková Z AU - Kikerlová S AU - Sadowski J AU - Šnorek M AU - Sandner P AU - Červenka L PY - 2026 JO - Journal of hypertension DO - 10.1097/hjh.0000000000004422 UR - https://doi.org/10.1097/hjh.0000000000004422 ER -
APA
M, H., M, M., P, Š., Z, V., S, K., J, S., M, Š., P, S., & L, Č. (2026). Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.. Journal of hypertension. https://doi.org/10.1097/hjh.0000000000004422
Source records
- pubmed · retrieved 2026-09-26T19:23:54.039Z